Effect of first-line molecular targeted agents on the efficacy of second-line bevacizumab-containing regimen for metastatic colorectal cancer.

被引：0
|
作者：
Hasegawa, Hiroko
Taniguchi, Hiroya
Mitani, Seiichiro
Komori, Azusa
Masuishi, Toshiki
Narita, Yukiya
Kadowaki, Shigenori
Ura, Takashi
Andoh, Masashi
Muro, Kei
机构：
[1] Aichi Canc Ctr Hosp, Dept Clin Oncol, Nagoya, Aichi 464, Japan
[2] Aichi Canc Ctr Hosp, Nagoya, Aichi 464, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 04期
关键词：
D O I：
10.1200/jco.2016.34.4_suppl.748
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
748
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Bevacizumab and aflibercept in second-line metastatic colorectal cancer: 12 years of experience
    Raquel Claramunt García
    Carmen Lucía Muñoz Cid
    Andrés Sánchez Ruiz
    Juan Francisco Marín Pozo
    [J]. European Journal of Clinical Pharmacology, 2022, 78 : 287 - 291
  • [32] SAFETY AND EFFICACY OF BEVACIZUMAB WITH FIRST-LINE FOLFIRI FOR METASTATIC COLORECTAL CANCER: SINGLE CENTER EXPERIENCE
    De Sanctis, R.
    Longo, F.
    Gori, B.
    Zivi, A.
    Del Signore, E.
    Proietti, E.
    De Filippis, L.
    Stumbo, L.
    Quadrini, S.
    Di Seri, M.
    [J]. ANNALS OF ONCOLOGY, 2008, 19 : 145 - 145
  • [33] Safety and efficacy of bevacizumab with first-line FOLFIRI for metastatic colorectal cancer: Single center experience
    Longo, F.
    De Sanctis, R.
    Quadrini, S.
    Stumbo, L.
    Del Signore, E.
    Gori, B.
    De Filippis, L.
    Di Seri, M.
    [J]. ANNALS OF ONCOLOGY, 2008, 19 : 91 - 92
  • [34] Target hepatic artery regional chemotherapy and bevacizumab perfusion in liver metastatic colorectal cancer after failure of first-line or second-line systemic chemotherapy
    Chen, Hui
    Zhang, Ji
    Cao, Guang
    Liu, Peng
    Xu, Haifeng
    Wang, Xiaodong
    Zhu, Xu
    Gao, Song
    Guo, Jianhai
    Zhu, Linzhong
    Zhang, Pengjun
    [J]. ANTI-CANCER DRUGS, 2016, 27 (02) : 118 - 126
  • [35] Efficacy and safety of bevacizumab in combination with irinotecan and capecitabine in first-line treatment of metastatic colorectal cancer
    Jungic, Sasa
    Tubic, Biljana
    Gajanin, Radoslav
    Gojkovic, Zdenka
    Rakita, Ivanka
    [J]. VOJNOSANITETSKI PREGLED, 2017, 74 (03) : 249 - 255
  • [36] Efficacy and safety of CapeIRI plus bevacizumab therapy as a second-line treatment for patients with metastatic colorectal cancer
    Sunagawa, Y.
    Nakayama, G.
    Hattori, N.
    Ezaka, K.
    Uda, H.
    Umeda, S.
    Sato, B.
    Yamada, S.
    Sugimito, H.
    Koike, M.
    Kodera, Y.
    [J]. ANNALS OF ONCOLOGY, 2017, 28
  • [37] Effectiveness of bevacizumab in first- and second-line treatment for metastatic colorectal cancer: ITACa randomized trial
    Petracci, Elisabetta
    Scarpi, Emanuela
    Passardi, Alessandro
    Biggeri, Annibale
    Milandri, Carlo
    Vecchia, Stefano
    Gelsomino, Fabio
    Tassinari, Davide
    Tamberi, Stefano
    Bernardini, Ilaria
    Accettura, Caterina
    Frassineti, Giovanni Luca
    Amadori, Dino
    Nanni, Oriana
    [J]. THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2020, 12
  • [38] Second-line therapy for metastatic colorectal cancer
    Price, Timothy J.
    [J]. LANCET ONCOLOGY, 2015, 16 (05): : 476 - 477
  • [39] Second-line management of metastatic colorectal cancer
    Gallagher, David J.
    Kemeny, Nancy
    [J]. CLINICAL COLORECTAL CANCER, 2008, 7 (01) : 25 - 32
  • [40] Hypertension as predictive factor for bevacizumab-containing first-line therapy in metastatic breast and colorectal cancer in BRECOL (GEICAM/2011-04) study
    Rodriguez-Lescure, Alvaro
    Gallego, Javier
    Garcia-Alfonso, Pilar
    Massuti, Bartomeu
    Marquez, Raul
    Calvo, Lourdes
    Sanchez-Rovira, Pedro
    Anton, Antonio
    Chacon, Jose Ignacio
    Ciruelos, Eva
    Ponce, Jose Juan
    Santaballa, Ana
    Valladares-Ayerbes, Manuel
    Duenas, Maria Rosario
    Alonso, Vicente
    Aparicio, Jorge
    Encinas, Sara
    Robles, Luis
    Escudero, Maria Jose
    Caballero, Rosalia
    Bezares, Susana
    de la Haba-Rodriguez, Juan
    [J]. CLINICAL & TRANSLATIONAL ONCOLOGY, 2024, 26 (08): : 1896 - 1907
12345